Imitrex Injection
Product Images NDC 0173-0739

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Imitrex (NDC 0173-0739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan Chemical Structure (Imitrex Inj Spl Graphic 01)

FDA Label Image

Imitrex Inj Graph Time To Relief V3-01 (Imitrex Inj Spl Graphic 02)

Imitrex Inj Graph Time To Relief V3-01 (Imitrex Inj Spl Graphic 02)
This appears to be a graph showing the estimated percentage of patients with relief from a placebo and a medication called IMITREX over a period of time in minutes. The x-axis is labeled as time in minutes with data points at 10, 15, 20, and 25 minutes. The y-axis appears to be labeled as the percentage of patients with relief and ranges from 0 to 100 with data points at 0, 20, 40, 60, 80, and 100%. The graph shows that at all time points, significantly more patients taking IMITREX experienced relief than those taking placebo.*
FDA Label Image

Statdose System (Imitrex Inj Spl Graphic 03)

FDA Label Image

Carrying Case (Imitrex Inj Spl Graphic 04)

Carrying Case (Imitrex Inj Spl Graphic 04)
This text seems to be describing a medical product used for carrying and administering medication. It mentions a blue button, syringe cartridges, a cartridge labeled "IMITREX", and a pack for a STATdose Pen. However, there is not enough information to understand the specific use or purpose of this product.*
FDA Label Image

Figure A (Imitrex Inj Spl Graphic 05)

FDA Label Image

Figure B (Imitrex Inj Spl Graphic 06)

Figure B (Imitrex Inj Spl Graphic 06)
A tool called Priming Rod is being referred to. However, without additional context, it is unclear what this tool is used for or its specific features.*
FDA Label Image

Figure C (Imitrex Inj Spl Graphic 07)

FDA Label Image

Figure D (Imitrex Inj Spl Graphic 08)

FDA Label Image

Figure E (Imitrex Inj Spl Graphic 09)

FDA Label Image

Figure F (Imitrex Inj Spl Graphic 10)

FDA Label Image

Figure G (Imitrex Inj Spl Graphic 11)

FDA Label Image

Figure H (Imitrex Inj Spl Graphic 12)

FDA Label Image

Figure I (Imitrex Inj Spl Graphic 13)

FDA Label Image

Figure J (Imitrex Inj Spl Graphic 14)

FDA Label Image

Figure K (Imitrex Inj Spl Graphic 15)

FDA Label Image

Figure L (Imitrex Inj Spl Graphic 16)

FDA Label Image

Figure M (Imitrex Inj Spl Graphic 17)

FDA Label Image

Figure N (Imitrex Inj Spl Graphic 18)

FDA Label Image

Figure O (Imitrex Inj Spl Graphic 19)

FDA Label Image

Figure P (Imitrex Inj Spl Graphic 20)

FDA Label Image

Figure Q (Imitrex Inj Spl Graphic 21)

FDA Label Image

Imitrex Injection 4mg Cartridge Label (Imitrex Inj Spl Graphic 22)

FDA Label Image

Imitrex Injection 6mg Cartridge Label (Imitrex Inj Spl Graphic 23)

Imitrex Injection 6mg Cartridge Label (Imitrex Inj Spl Graphic 23)
This is a description for M Trey Injection, which comes in 2 single-dose syringe cartridges with NDC number 0173-0478-00. The injection is intended for subcutaneous administration only, with a volume of 0.5 ml per dosage. There is not enough information to understand what the injection is used for.*
FDA Label Image

Imitrex Injection 6mg Vial Carton (Imitrex Inj Spl Graphic 24)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.